The global lamotrigine market is expected to rise at a considerable CAGR during the forecast period (2022-2028). Lamotrigine is an epileptic drug that also enables calm moods in people with bipolar illness. Dramatic swings in mood, energy, and activity levels characterize bipolar disorder, limiting a person's capacity to carry out day-to-day responsibilities. It is used to treat partial seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome generalized seizures. It enables to keep the brain's electrical system in check. Bipolar disorder affects roughly 5.7 million adults in the United States each year, or about 2.6 percent of the population aged 18 and over, according to the National Institute of Mental Health (NIMH). Furthermore, bipolar disorder has a median age of 25 years, but it can begin as early as childhood or as late as 40-50 years of age. Furthermore, according to the World Health Organization (WHO), epilepsy is one of the most common neurological illnesses in the world, affecting around 50 million individuals. As a result of the rising frequency of epilepsy and bipolar illness, demand for lamotrigine is increasing, enhancing market growth. Moreover, growing awareness about epilepsy among the people and increasing government funding, drugs reimbursement options will act as an opportunity for the market

Impact of COVID-19 on Global Lamotrigine Market.

Covid-19 has already produced a great impact on the global lamotrigine market. Seizures and epilepsy are among the complications that the virus can produce in the nervous system in Covid-19 patients, epilepsy seizures can occur as a result of strokes, electrolyte imbalances, increased oxidative stress, and mitochondrial dysfunction. Due to the rapid increase in the number of Covid-19 cases, the demand for Lamotrigine has also risen, thus boom the lamotrigine market globally.

Segmental Outlook 

The global lamotrigine market is segmented based on type and application. Based on the type, the market is sub-segmented into Purity 98%-99% and Purity 99%. Based on the application, the market is sub-segmented into Epilepsy, Bipolar Disorder. 

Global Lamotrigine Market Share by Type, 2021(%)

The Purity 98%-99% Segment is anticipated to Hold a Prominent Share in the Global Lamotrigine Market.

The Purity 98%-99% Segment is anticipated to hold a significant share in the market. Fortunately, this industry is humming with research and development efforts aimed at improving the technology behind mental-disorder drugs for the benefit of both the pharmaceutical company and the patients it serves. 

Regional Outlooks

The Global Lamotrigine market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).  **The market can be analyzed for a particular region or country level as per the requirement.

Global Lamotrigine Market Growth, by Region 2022-2028

The North America Region is Estimated to Hold the Major Share in the Global Lamotrigine Market

The market in the North America captured a substantial revenue share in 2021 due to technological advancements and owing to the presence of a larger number of drug manufacturing companies and more awareness among the population. Major players are in the process of continuous research and development for more innovations of drugs that they can launch to cure the disease of acute infections. 

Market Players Outlook

The major companies serving the global Lamotrigine Tetrahedron Manufacturing Services, Polpharma Company, Vignesh Life Sciences, Jubilant FoodWorks Limited, IOL Chemicals and Pharmaceuticals Limited, and Veeprho Pharmaceuticals s.r.o. The market players are considerably contributing to the market growth by the adoption of various strategies Including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. 

The Report Covers

• Market value data analysis of 2022 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the Global Lamotrigine Market. Based on the availability of data, information related to new product launches, and relevant news is additionally available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.